Modulating Neuroinflammation to Treat Neuropsychiatric Disorders
Joint Authors
Radtke, Franziska A.
Chapman, Gareth
Hall, Jeremy
Syed, Yasir A.
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-21, 21 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-10-18
Country of Publication
Egypt
No. of Pages
21
Main Subjects
Abstract EN
Neuroinflammation is recognised as one of the potential mechanisms mediating the onset of a broad range of psychiatric disorders and may contribute to nonresponsiveness to current therapies.
Both preclinical and clinical studies have indicated that aberrant inflammatory responses can result in altered behavioral responses and cognitive deficits.
In this review, we discuss the role of inflammation in the pathogenesis of neuropsychiatric disorders and ask the question if certain genetic copy-number variants (CNVs) associated with psychiatric disorders might play a role in modulating inflammation.
Furthermore, we detail some of the potential treatment strategies for psychiatric disorders that may operate by altering inflammatory responses.
American Psychological Association (APA)
Radtke, Franziska A.& Chapman, Gareth& Hall, Jeremy& Syed, Yasir A.. 2017. Modulating Neuroinflammation to Treat Neuropsychiatric Disorders. BioMed Research International،Vol. 2017, no. 2017, pp.1-21.
https://search.emarefa.net/detail/BIM-1137405
Modern Language Association (MLA)
Radtke, Franziska A.…[et al.]. Modulating Neuroinflammation to Treat Neuropsychiatric Disorders. BioMed Research International No. 2017 (2017), pp.1-21.
https://search.emarefa.net/detail/BIM-1137405
American Medical Association (AMA)
Radtke, Franziska A.& Chapman, Gareth& Hall, Jeremy& Syed, Yasir A.. Modulating Neuroinflammation to Treat Neuropsychiatric Disorders. BioMed Research International. 2017. Vol. 2017, no. 2017, pp.1-21.
https://search.emarefa.net/detail/BIM-1137405
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1137405